BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 28936523)

  • 1. Mesoporous ZnO nanocapsules for the induction of enhanced antigen-specific immunological responses.
    Afroz S; Medhi H; Maity S; Minhas G; Battu S; Giddaluru J; Kumar K; Paik P; Khan N
    Nanoscale; 2017 Oct; 9(38):14641-14653. PubMed ID: 28936523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delivering all in one: Antigen-nanocapsule loaded with dual adjuvant yields superadditive effects by DC-directed T cell stimulation.
    Paßlick D; Piradashvili K; Bamberger D; Li M; Jiang S; Strand D; R Wich P; Landfester K; Bros M; Grabbe S; Mailänder V
    J Control Release; 2018 Nov; 289():23-34. PubMed ID: 30219277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesoporous silica particles potentiate antigen-specific T-cell responses.
    Kupferschmidt N; Qazi KR; Kemi C; Vallhov H; Garcia-Bennett AE; Gabrielsson S; Scheynius A
    Nanomedicine (Lond); 2014; 9(12):1835-46. PubMed ID: 25325240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zinc oxide nanoparticles provide an adjuvant effect to ovalbumin via a Th2 response in Balb/c mice.
    Roy R; Kumar S; Verma AK; Sharma A; Chaudhari BP; Tripathi A; Das M; Dwivedi PD
    Int Immunol; 2014 Mar; 26(3):159-72. PubMed ID: 24225181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vault nanocapsules as adjuvants favor cell-mediated over antibody-mediated immune responses following immunization of mice.
    Kar UK; Jiang J; Champion CI; Salehi S; Srivastava M; Sharma S; Rabizadeh S; Niazi K; Kickhoefer V; Rome LH; Kelly KA
    PLoS One; 2012; 7(7):e38553. PubMed ID: 22808011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of ultrafine zinc oxide (ZnO) nanoparticles on induction of oral tolerance in mice.
    Matsumura M; Takasu N; Nagata M; Nakamura K; Kawai M; Yoshino S
    J Immunotoxicol; 2010; 7(3):232-7. PubMed ID: 20507255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microdosed Lipid-Coated (67)Ga-Magnetite Enhances Antigen-Specific Immunity by Image Tracked Delivery of Antigen and CpG to Lymph Nodes.
    Ruiz-de-Angulo A; Zabaleta A; Gómez-Vallejo V; Llop J; Mareque-Rivas JC
    ACS Nano; 2016 Jan; 10(1):1602-18. PubMed ID: 26678549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reconstituted dry powder formulations of ZnO-adjuvanted ovalbumin induce equivalent antigen specific antibodies but lower T cell responses than ovalbumin adjuvanted with Alhydrogel® or cationic adjuvant formulation 01 (CAF®01).
    Hellfritzsch M; Christensen D; Foged C; Scherließ R; Thakur A
    Int J Pharm; 2023 Dec; 648():123581. PubMed ID: 37931728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. OVA-bound nanoparticles induce OVA-specific IgG1, IgG2a, and IgG2b responses with low IgE synthesis.
    Yanase N; Toyota H; Hata K; Yagyu S; Seki T; Harada M; Kato Y; Mizuguchi J
    Vaccine; 2014 Oct; 32(45):5918-24. PubMed ID: 25211769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual role of CpG as immune modulator and physical crosslinker in ovalbumin loaded N-trimethyl chitosan (TMC) nanoparticles for nasal vaccination.
    Slütter B; Jiskoot W
    J Control Release; 2010 Nov; 148(1):117-121. PubMed ID: 20600405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel lipid nanoparticle adjuvant significantly enhances B cell and T cell responses to sub-unit vaccine antigens.
    Swaminathan G; Thoryk EA; Cox KS; Meschino S; Dubey SA; Vora KA; Celano R; Gindy M; Casimiro DR; Bett AJ
    Vaccine; 2016 Jan; 34(1):110-9. PubMed ID: 26555351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intradermal vaccination with hollow microneedles: A comparative study of various protein antigen and adjuvant encapsulated nanoparticles.
    Du G; Hathout RM; Nasr M; Nejadnik MR; Tu J; Koning RI; Koster AJ; Slütter B; Kros A; Jiskoot W; Bouwstra JA; Mönkäre J
    J Control Release; 2017 Nov; 266():109-118. PubMed ID: 28943194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-adjuvanting polymeric nanovaccines enhance IFN production and cytotoxic T cell response.
    Zhao M; He C; Zheng X; Jiang M; Xie Z; Wei H; Zhang S; Lin Y; Zhang J; Sun X
    J Control Release; 2024 May; 369():556-572. PubMed ID: 38580136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological adjuvant effect of Boswellia serrata (BOS 2000) on specific antibody and cellular response to ovalbumin in mice.
    Gupta A; Khajuria A; Singh J; Singh S; Suri KA; Qazi GN
    Int Immunopharmacol; 2011 Aug; 11(8):968-75. PubMed ID: 21371582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant effect of zinc oxide on Th2 but not Th1 immune responses in mice.
    Matsumura M; Nagata M; Nakamura K; Kawai M; Baba T; Yamaki K; Yoshino S
    Immunopharmacol Immunotoxicol; 2010 Mar; 32(1):56-62. PubMed ID: 19811107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guanidinylated cationic nanoparticles as robust protein antigen delivery systems and adjuvants for promoting antigen-specific immune responses in vivo.
    Li P; Shi G; Zhang X; Song H; Zhang C; Wang W; Li C; Song B; Wang C; Kong D
    J Mater Chem B; 2016 Sep; 4(33):5608-5620. PubMed ID: 32263357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A CCR4 antagonist enhances DC activation and homing to the regional lymph node and shows potent vaccine adjuvant activity through the inhibition of regulatory T-cell recruitment.
    Yamamoto S; Matsuo K; Nagakubo D; Higashiyama S; Nishiwaki K; Oiso N; Kawada A; Yoshie O; Nakayama T
    J Pharmacol Sci; 2018 Mar; 136(3):165-171. PubMed ID: 29519579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type 1 and 2 immunity following vaccination is influenced by nanoparticle size: formulation of a model vaccine for respiratory syncytial virus.
    Mottram PL; Leong D; Crimeen-Irwin B; Gloster S; Xiang SD; Meanger J; Ghildyal R; Vardaxis N; Plebanski M
    Mol Pharm; 2007; 4(1):73-84. PubMed ID: 17274665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. pH-Responsive Poly(D,L-lactic-co-glycolic acid) Nanoparticles with Rapid Antigen Release Behavior Promote Immune Response.
    Liu Q; Chen X; Jia J; Zhang W; Yang T; Wang L; Ma G
    ACS Nano; 2015 May; 9(5):4925-38. PubMed ID: 25898266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of ovalbumin-specific Th1, Th2, and Th17 immune responses by amorphous silica nanoparticles.
    Toda T; Yoshino S
    Int J Immunopathol Pharmacol; 2016 Sep; 29(3):408-20. PubMed ID: 27343242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.